Roy Lester Freeman - 25 Jun 2021 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Milton H. Werner, attorney-in-fact
Issuer symbol
IKT
Transactions as of
25 Jun 2021
Net transactions value
$0
Form type
4
Filing time
29 Jun 2021, 19:10:25 UTC
Next filing
28 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (right to buy) Award $0 +22,677 $0.000000 22,677 25 Jun 2021 Common Stock 22,677 $2.92 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.